These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 17585817)
21. 2-O-(2-Aminoethyl)-myo-inositol 1,4,5-trisphosphate as a novel ligand for conjugation: physicochemical properties and synthesis of a new Ins(1,4,5)P(3) affinity matrix. Riley AM; Dozol H; Spiess B; Potter BV Biochem Biophys Res Commun; 2004 May; 318(2):444-52. PubMed ID: 15120621 [TBL] [Abstract][Full Text] [Related]
22. Both d- and l-Glucose Polyphosphates Mimic d- Shipton ML; Riley AM; Rossi AM; Brearley CA; Taylor CW; Potter BVL J Med Chem; 2020 May; 63(10):5442-5457. PubMed ID: 32286062 [TBL] [Abstract][Full Text] [Related]
23. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors. Murphy CT; Bullock AJ; Lindley CJ; Mills SJ; Riley AM; Potter BV; Westwick J Mol Pharmacol; 1996 Nov; 50(5):1223-30. PubMed ID: 8913354 [TBL] [Abstract][Full Text] [Related]
24. Synthesis and binding properties of cyclopentane analogues of myo-inositol 1,4,5-tris(phosphate). Moris MA; Caron AZ; Guillemette G; Schlewer G Bioorg Med Chem; 2004 Aug; 12(15):3995-4001. PubMed ID: 15246076 [TBL] [Abstract][Full Text] [Related]
25. Chemoselective alcoholysis/acetolysis of trans-ketals over cis-ketals and its application in the total synthesis of the cellular second messenger, D-myo-inositol-1,4,5-trisphosphate. Vidyasagar A; Pathigoolla A; Sureshan KM Org Biomol Chem; 2013 Sep; 11(33):5443-53. PubMed ID: 23851711 [TBL] [Abstract][Full Text] [Related]
26. Synthesis of analogues of myo-inositol 1,4,5-trisphosphate that contain sulfonamide, sulfate, methylphosphonate, and carboxymethyl groups. Westerduin P; Willems HA; van Boeckel CA Carbohydr Res; 1992 Oct; 234():131-40. PubMed ID: 1334798 [TBL] [Abstract][Full Text] [Related]
27. Molecular recognition at the myo-inositol 1,4,5-trisphosphate receptor. 3-position substituted myo-inositol 1,4,5-trisphosphate analogues reveal the binding and Ca2+ release requirements for high affinity interaction with the myo-inositol 1,4,5-trisphosphate receptor. Wilcox RA; Challiss RA; Traynor JR; Fauq AH; Ognayanov VI; Kozikowski AP; Nahorski SR J Biol Chem; 1994 Oct; 269(43):26815-21. PubMed ID: 7929418 [TBL] [Abstract][Full Text] [Related]
28. Synthetic D- and L-enantiomers of 2,2-difluoro-2-deoxy-myo-inositol 1,4,5-trisphosphate interact differently with myo-inositol 1,4,5-trisphosphate binding proteins: identification of a potent small molecule 3-kinase inhibitor. Safrany ST; Sawyer DA; Nahorski SR; Potter BV Chirality; 1992; 4(7):415-22. PubMed ID: 1334423 [TBL] [Abstract][Full Text] [Related]
29. Divergent syntheses of all possible optically active regioisomers of myo-inositol tris- and tetrakisphosphates. Chung SK; Kwon YU; Shin JH; Chang YT; Lee C; Shin BG; Kim KC; Kim MJ J Org Chem; 2002 Aug; 67(16):5626-37. PubMed ID: 12153261 [TBL] [Abstract][Full Text] [Related]
30. Synthesis, calcium mobilizing, and physicochemical properties of D-chiro-inositol 1,3,4,6-tetrakisphosphate, a novel and potent ligand at the D-myo-inositol 1,4,5-trisphosphate receptor. Liu C; Davis RJ; Nahorski SR; Ballereau S; Spiess B; Potter BV J Med Chem; 1999 Jun; 42(11):1991-8. PubMed ID: 10354407 [TBL] [Abstract][Full Text] [Related]
31. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor. Safrany ST; Wilcox RA; Liu C; Dubreuil D; Potter BV; Nahorski SR Mol Pharmacol; 1993 Apr; 43(4):499-503. PubMed ID: 8386304 [TBL] [Abstract][Full Text] [Related]
32. C-glycoside based mimics of D-myo-inositol 1,4,5-trisphosphate. Rosenberg HJ; Riley AM; Correa V; Taylor CW; Potter BV Carbohydr Res; 2000 Oct; 329(1):7-16. PubMed ID: 11086681 [TBL] [Abstract][Full Text] [Related]
33. Pretreatment with D-myo-inositol trisphosphate reduces infarct size in rabbit hearts: role of inositol trisphosphate receptors and gap junctions in triggering protection. Przyklenk K; Maynard M; Darling CE; Whittaker P J Pharmacol Exp Ther; 2005 Sep; 314(3):1386-92. PubMed ID: 15919762 [TBL] [Abstract][Full Text] [Related]
34. Modification at C2 of myo-inositol 1,4,5-trisphosphate produces inositol trisphosphates and tetrakisphosphates with potent biological activities. Wilcox RA; Safrany ST; Lampe D; Mills SJ; Nahorski SR; Potter BV Eur J Biochem; 1994 Jul; 223(1):115-24. PubMed ID: 8033885 [TBL] [Abstract][Full Text] [Related]
36. The Ca2+ release activities of D-myo-inositol 1,4,5-trisphosphate analogs are quantized. Denis GV; Ballou CE Cell Calcium; 1991 Jun; 12(6):395-401. PubMed ID: 1884394 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological properties of 2-substituted myo-inositol 1,4,5-trisphosphate analogues directed toward affinity chromatography and photoaffinity labeling. Ozaki S; Watanabe Y; Ogasawara T; Hirata M; Kanematsu T Carbohydr Res; 1992 Oct; 234():189-206. PubMed ID: 1468078 [TBL] [Abstract][Full Text] [Related]
38. The preparation of intermediates for the synthesis of 1D-myo-inositol 1,4,5-trisphosphate, a second messenger for signal transduction in cells. Desai T; Gigg J; Gigg R; Payne S; Penades S Carbohydr Res; 1992 Oct; 234():1-21. PubMed ID: 1468077 [TBL] [Abstract][Full Text] [Related]
39. Effect of myo-inositol(1,4,5)trisphosphate on the hydrolysis of phytic acid by phytase. Padmanabhan U; Dasgupta S; Biswas BB; Dasgupta D Indian J Biochem Biophys; 2001; 38(1-2):53-5. PubMed ID: 11563331 [TBL] [Abstract][Full Text] [Related]
40. Recognition of myo-inositol 1,4,5-trisphosphate using a fluorescent imidazolium receptor. Jung JY; Jun EJ; Kwon YU; Yoon J Chem Commun (Camb); 2012 Aug; 48(64):7928-30. PubMed ID: 22763433 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]